Skip to main content
OpenTrials

Clinical trial condition

Neoplasms by Histologic Type

Explore clinical trials studying Neoplasms by Histologic Type. Study availability and eligibility vary by location and protocol.

30,162 public trials 6,471 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms by Histologic Type trial results

Recruiting

L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML

NCT06788756

Conditions
Acute Myeloid Leukaemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Bioresearch Partners Miami, Florida, United States
  • Augusta University - Georgia Cancer Center Augusta, Georgia, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
  • Atlantic Health Morristown, New Jersey, United States
View all 28 locations
View Trial Details
Recruiting

Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance

NCT05796375

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • West Haven VA Medical Center West Haven, Connecticut, United States
  • Bay Pines VA Healthcare System Bay Pines, Florida, United States
  • James A. Haley Veterans' Hospital Tampa, Florida, United States
  • VA Boston Jamaica Plains Campus West Roxbury, Massachusetts, United States
View Trial Details
Recruiting

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

NCT05176483

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +48 more
Locations
  • Exelixis Clinical Site #67 Phoenix, Arizona, United States
  • Exelixis Clinical Site #1 Tucson, Arizona, United States
  • Exelixis Clinical Site #123 Palo Alto, California, United States
  • Exelixis Clinical Site #59 Santa Barbara, California, United States
View all 122 locations
View Trial Details
Recruiting

A Study to Assess the Safety and Anti-Tumor Activity of REGN7945 in Combination With Linvoseltamab in Adult Participants With Relapsed/Refractory Multiple Myeloma

NCT06669247

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Royal Prince Alfred Hospital Sydney, New South Wales, Australia
  • Illawarra Cancer Care Centre Wollongong, New South Wales, Australia
  • Pindara Private Hospital Benowa, Queensland, Australia
  • Royal Adelaide Hospital Adelaide, South Australia, Australia
View Trial Details
Recruiting

AB122 Platform Study

NCT04999761

Conditions
Advanced or Metastatic Solid Tumor, Alveolar Soft Part Sarcoma, Biliary Tract Cancer, +41 more
Locations
  • A site selected by Taiho Pharmaceutical Co., Ltd. Aichi, Japan
  • A site selected by Taiho Pharmaceutical Co., Ltd. Chiba, Japan
  • A site selected by Taiho Pharmaceutical Co., Ltd. Ehime, Japan
  • A site selected by Taiho Pharmaceutical Co., Ltd. Hokkaido, Japan
View Trial Details
Recruiting

GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of Adult Acute Lymphoblastic Leukemia (ALL) Patients and Related Diseases Associated With a Prospective Collection of Biomaterial

NCT02872987

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
Locations
  • Universitätsklinikum Graz Graz, Austria
  • LKH-Hochsteiermark Leoben Leoben, Austria
  • Hanusch-Krankenhaus Wien Vienna, Austria
  • University Hospital of Frankfurt (Main) Frankfurt am Main, Hesse, Germany
View all 147 locations
View Trial Details

Related conditions